trigram

This is a table of type trigram and their frequencies. Use it to search & browse the list to learn more about your study carrel.

trigram	frequency
severe acute respiratory	202
infectious bronchitis virus	200
as well as	199
acute respiratory syndrome	195
the use of	157
respiratory syndrome coronavirus	150
the presence of	143
the development of	137
in this study	136
cd t cells	131
west nile virus	116
based on the	115
in order to	114
respiratory syncytial virus	109
of the vaccine	109
the number of	101
due to the	98
of the virus	97
one of the	95
balb c mice	92
a number of	90
the united states	89
compared to the	87
data not shown	87
in the united	86
middle east respiratory	85
east respiratory syndrome	85
cd t cell	82
shown in fig	81
as shown in	80
been shown to	77
t cell responses	76
a and b	75
according to the	75
avian infectious bronchitis	73
cd and cd	72
in the us	71
rift valley fever	71
and immunogenicity of	70
a total of	68
h n vaccine	67
cellular immune responses	66
the absence of	66
the s protein	65
the role of	63
years of age	63
the risk of	62
in addition to	61
vesicular stomatitis virus	60
safety and immunogenicity	60
to determine the	59
of infectious bronchitis	59
for h at	58
development of a	58
morbidity and mortality	58
was used to	58
and respiratory syndrome	58
the frequency of	57
in the s	57
the immune response	57
the control group	55
porcine reproductive and	55
in the presence	55
the effect of	55
were used to	55
immune responses to	55
reproductive and respiratory	55
immune response to	54
at the time	54
the incidence of	53
the efficacy of	53
the results of	53
in the control	53
shown to be	52
p and p	52
the majority of	52
at room temperature	52
the importance of	52
the level of	52
of severe acute	51
found to be	50
humoral and cellular	50
to evaluate the	50
and cellular immune	50
the ability of	50
world health organization	49
the production of	49
a variety of	49
the present study	49
the time of	48
immune responses in	48
observed in the	48
a h n	48
the impact of	48
the end of	47
mhc class i	47
high levels of	47
the expression of	47
in terms of	46
on the other	46
respiratory syndrome virus	46
mice immunized with	46
vaccinia virus ankara	45
was observed in	45
as previously described	45
the need for	45
in the absence	45
of h n	45
the spike protein	45
it has been	44
analysis of the	44
safety and efficacy	44
were found to	44
modified vaccinia virus	43
in older adults	43
h n influenza	43
immunogenicity of a	43
the other hand	43
and cd t	43
there is a	42
as a result	41
of neutralizing antibodies	41
that of the	41
human immunodeficiency virus	41
when compared to	41
of the s	41
of the viral	41
has been shown	40
in contrast to	40
as described previously	40
detected in the	40
of influenza virus	40
mvaik rsv g	40
the ability to	39
in response to	39
there is no	39
was used as	39
were challenged with	39
mvaik rsv f	39
end of the	39
and in the	39
mlv mtb wcl	39
of avian infectious	39
some of the	39
cells in the	39
in the present	39
for min at	38
was detected in	38
of the immune	38
for use in	38
the percentage of	38
and efficacy of	38
of the disease	38
neutralizing antibody titers	38
a systematic review	38
used as a	38
such as the	37
ck ch lhlj	37
there was a	37
showed that the	37
ch lhlj v	37
of a vaccine	37
c for min	36
polymerase chain reaction	36
the immune system	36
humoral immune responses	36
of the most	36
the induction of	36
in the vaccine	36
was carried out	36
in our study	35
based on a	35
in the same	35
increase in the	35
t cells in	35
the detection of	35
of a novel	35
feline infectious peritonitis	35
need to be	35
have shown that	35
with mvaik rsv	35
results showed that	35
the authors declare	34
and characterization of	34
of this study	34
of influenza a	34
there was no	34
was determined by	34
the fact that	34
a result of	34
the brighton collaboration	34
in the trachea	34
the generation of	34
the case of	34
the control of	34
in animal models	33
obtained from the	33
part of the	33
in the lungs	33
in this paper	33
the respiratory tract	33
each of the	33
the context of	33
was added to	33
to assess the	33
b and c	33
the immunogenicity of	33
in vitro and	33
of cd t	33
were detected in	33
as part of	33
role in the	33
the n protein	32
used in the	32
shown in table	32
with respect to	32
have been shown	32
for vaccine development	32
in the context	32
protective efficacy of	32
vaccines have been	32
an important role	32
modified vaccinia ankara	32
related to the	32
most of the	32
of west nile	32
this study was	32
at days post	31
all of the	31
the levels of	31
seasonal influenza vaccine	31
of a recombinant	31
samples were collected	31
the lack of	31
in the case	31
used for the	31
control and prevention	31
viral vector vaccines	31
serum samples were	31
the proportion of	31
a dose of	31
were used for	30
a single dose	30
transmissible gastroenteritis virus	30
for disease control	30
be used to	30
of the study	30
at the end	30
can be used	30
associated with the	30
use of the	30
were observed in	30
influenza vaccine in	30
the vaccine was	30
mouth disease virus	30
in balb c	30
well as the	30
it is not	30
in the study	30
important role in	30
weeks of age	29
efficacy of a	29
included in the	29
the prevention of	29
of a new	29
in vero cells	29
authors declare that	29
the surface of	29
as a vaccine	29
as compared to	29
at the same	29
sequence of the	29
an increase in	29
the h n	29
because of the	29
the severe acute	29
are shown in	29
immune response in	28
may not be	28
to participate in	28
ability of the	28
and stored at	28
centers for disease	28
it is possible	28
of the n	28
disease control and	28
acute otitis media	28
associated with a	28
the potential to	28
of the sars	28
to develop a	28
the world health	28
with regard to	28
as described above	27
were obtained from	27
in the field	27
to be a	27
has also been	27
none of the	27
h n pandemic	27
and in vivo	27
a novel coronavirus	27
assessment of the	27
was associated with	27
compared with the	27
found in the	27
has not been	27
was supported by	27
protective immunity in	27
immune responses against	26
were determined by	26
a range of	26
s tr protein	26
that they have	26
caused by the	26
influenza vaccination in	26
the potential for	26
c mice were	26
in recent years	26
seasonal influenza vaccination	26
has been reported	26
similar to the	26
for the development	26
expression of the	26
the vaccine and	26
the effects of	26
it is important	26
in developing countries	26
was found to	26
changes in the	26
influenza a virus	26
t cells were	26
used in this	26
contribute to the	26
around the world	26
declare that they	26
were infected with	26
vitro and in	26
immune responses and	26
in the past	26
with severe acute	26
of influenza vaccination	26
those of the	25
the spread of	25
of the human	25
the cost of	25
during the first	25
the plates were	25
a new caledonia	25
of lc m	25
response to the	25
the safety and	25
the cells were	25
influenza vaccine effectiveness	25
virus infection in	25
in the development	25
was used for	25
of influenza vaccine	25
is associated with	25
it may be	25
characterization of a	25
addition to the	25
likely to be	25
have also been	25
the vaccine is	25
the effectiveness of	25
were collected from	24
the introduction of	24
neutralizing antibodies against	24
reported in this	24
between the two	24
vaccine clinical trial	24
immunodeficiency virus type	24
differences in the	24
evaluation of the	24
the safety of	24
be used as	24
the s gene	24
consistent with the	24
have been reported	24
specific cd t	24
the current study	24
it can be	24
the burden of	24
with or without	24
can be found	24
derived from the	24
we found that	24
the possibility of	24
protective immunity against	24
were used as	24
to influence the	24
needs to be	24
more than one	24
t cell response	24
and incubated at	24
prevention and control	24
they have no	24
than that of	23
to identify the	23
and public health	23
of seasonal influenza	23
nci h cells	23
significantly higher than	23
the arkga p	23
approved by the	23
participate in a	23
was performed using	23
the results showed	23
the most common	23
immunized with mvaik	23
evaluation of a	23
valley fever virus	23
results of the	23
coronavirus spike protein	23
could not be	23
in the first	23
rsv g or	23
in mice and	23
added to the	23
supported by the	23
influenza and rsv	23
for a vaccine	23
no known competing	23
in the netherlands	23
for the prevention	23
were added to	23
on the surface	23
use of a	23
provided by the	23
development of vaccines	23
inactivated sars vaccine	23
vaccine in the	23
have no known	23
each group were	22
immunogenicity of the	22
c for h	22
the evaluation of	22
of s tr	22
recombinant vesicular stomatitis	22
financial interests or	22
in the future	22
which may be	22
a significant increase	22
are associated with	22
the favn assay	22
development of the	22
adjuvanted h n	22
the work reported	22
interests or personal	22
memory t cells	22
canine visceral leishmaniasis	22
of public health	22
human and animal	22
appeared to influence	22
humoral immune response	22
that could have	22
to accept a	22
summarized in table	22
competing financial interests	22
for the detection	22
there were no	22
of influenza b	22
or personal relationships	22
any of the	22
the last years	22
of the spike	22
of the recombinant	22
relationships that could	22
involved in the	22
known competing financial	22
of the total	22
were inoculated with	22
in hong kong	22
have appeared to	22
in embryonated eggs	22
levels of neutralizing	22
could have appeared	22
personal relationships that	22
red blood cells	22
were collected at	22
weeks after the	22
depending on the	22
is important to	22
the identification of	22
considered to be	22
in combination with	21
reduction in the	21
suggest that the	21
vaccine has been	21
is the most	21
a dna vaccine	21
of the influenza	21
c and d	21
region of the	21
influence the work	21
g or f	21
that can be	21
were collected and	21
in cotton rats	21
work reported in	21
to get vaccinated	21
is an important	21
characterization of the	21
to reduce the	21
it is likely	21
were immunized with	21
incubated for h	21
to investigate the	21
number of cases	21
to be used	21
significant increase in	21
the amount of	21
protein of the	21
indicated that the	21
have been developed	21
the availability of	21
as an adjuvant	21
viral load in	21
the most important	21
factors associated with	21
syndrome coronavirus spike	20
in the current	20
members of the	20
be due to	20
coronavirus infectious bronchitis	20
cytotoxic t lymphocytes	20
research and development	20
present in the	20
protective immune response	20
would like to	20
g for min	20
demonstrated that the	20
a live attenuated	20
h n virus	20
the placebo group	20
of the antibody	20
from each group	20
herpes simplex virus	20
cases and controls	20
for the presence	20
in the last	20
newcastle disease virus	20
in each group	20
of middle east	20
of specific igy	20
sera were collected	20
h n and	20
is needed to	20
s dna vaccine	20
and safety of	20
of influenza vaccines	20
more than of	20
future h n	20
results indicated that	20
simian immunodeficiency virus	20
of age and	20
has been used	20
higher than the	20
a reduction in	20
have not been	20
in which the	20
spike protein of	20
for detection of	20
the neutralizing antibody	20
of neutralizing antibody	20
to be the	20
a phase i	20
identification of a	20
for the first	20
the emergence of	20
colostrum and milk	20
at least one	20
virus in the	20
and days post	20
have been used	20
of a live	20
of the same	20
mice were vaccinated	19
specific immune responses	19
in patients with	19
is based on	19
influenza virus infection	19
old or older	19
wide range of	19
in herd b	19
influenza a h	19
years old or	19
is responsible for	19
to that of	19
against challenge with	19
days after vaccination	19
a decrease in	19
t cells and	19
like to thank	19
is likely to	19
of the world	19
of the genome	19
during the study	19
a role in	19
the increase in	19
trachea and kidney	19
were incubated at	19
national institutes of	19
responsible for the	19
it will be	19
the study period	19
ministry of health	19
due to a	19
in comparison to	19
neutralizing antibodies in	19
the activation of	19
cells were washed	19
nile virus infection	19
the duration of	19
years age group	19
le poly iclc	19
accept a future	19
for development of	19
the concentration of	19
to the vaccine	19
the poultry industry	19
in cell culture	19
department of health	19
months of age	19
correlates of protection	19
comparison of the	19
protective immune responses	19
resulted in a	19
be associated with	18
as described in	18
rna was extracted	18
in both the	18
a series of	18
willingness to accept	18
mice were immunized	18
rabbit haemorrhagic disease	18
of the two	18
the antibody response	18
the ad vector	18
the vector is	18
the innate immune	18
of the rh	18
analysis was performed	18
higher in the	18
of at least	18
in mammalian cells	18
of infectious diseases	18
single dose of	18
efficacy of the	18
the value of	18
and evaluation of	18
safe and effective	18
disease in the	18
antibodies to the	18
and it is	18
the university of	18
ml of the	18
cells infected with	18
in the population	18
have to be	18
fetal bovine serum	18
of the population	18
this article can	18
recombinant vaccinia virus	18
of mice with	18
a public health	18
in the elderly	18
in a single	18
amino acid changes	18
a future h	18
understanding of the	18
a and nci	18
the purpose of	18
days of age	18
animals and humans	18
be used in	18
this work was	18
and nci h	18
of the vaccinated	18
article can be	18
levels in the	18
igg and igg	18
embryonated chicken eggs	18
be used for	18
and mortality in	18
venezuelan equine encephalitis	18
it is a	18
and incubated for	18
is consistent with	18
institutes of health	18
modified live virus	18
cov s dna	18
were incubated with	18
vaccinated with the	18
that have been	18
emerging infectious diseases	18
rats immunized with	18
pandemic influenza a	18
plates were incubated	18
pandemic influenza vaccine	18
the influence of	18
were carried out	18
systematic review and	18
fc fusion protein	18
viral respiratory infections	18
prior to the	18
of the vector	18
a vaccine against	18
were vaccinated with	18
vaccines based on	18
of canine parvovirus	18
vaccine development and	17
veterinary and human	17
were able to	17
in the vaccinated	17
of immune response	17
the first time	17
adaptive immune responses	17
which have been	17
japanese encephalitis virus	17
indicating that the	17
days after the	17
were incubated for	17
the recombinant virus	17
added to each	17
been used to	17
to be effective	17
review of the	17
ep and cp	17
play an important	17
the magnitude of	17
appear to be	17
adjuvanted influenza a	17
a new vaccine	17
the public health	17
referred to as	17
dependent enhancement of	17
effects of the	17
the basis of	17
of dengue virus	17
the potential of	17
of the national	17
to determine whether	17
and animal health	17
hepatitis b vaccine	17
report of the	17
that could be	17
of a single	17
the same time	17
memory t cell	17
rsv subgroup a	17
respiratory disease in	17
infected with the	17
s tr expression	17
was obtained from	17
were included in	17
vaccine based on	17
republic of china	17
that in the	17
antibodies against rsv	17
influenza b virus	17
could be used	17
clinical signs and	17
antibody titers were	17
by flow cytometry	17
female balb c	17
should not be	17
induced by the	17
in saudi arabia	17
there has been	17
in accordance with	17
a lack of	17
a wide range	17
have been identified	17
a review of	17
cells were infected	17
upper respiratory tract	17
is not a	17
cotton rats immunized	17
identification of the	17
more likely to	17
of t cell	17
ibv ck ch	17
the wild type	16
innate immune response	16
to each well	16
equal volume of	16
between p and	16
of t cells	16
otitis media in	16
the type of	16
is expected to	16
with the exception	16
challenge with the	16
to enhance the	16
to ensure that	16
in the respiratory	16
viral rna replication	16
structure of the	16
is possible that	16
antibody titers in	16
many of the	16
levels of the	16
their ability to	16
antibody responses to	16
the severity of	16
one or more	16
regulatory t cells	16
in the day	16
to improve the	16
is likely that	16
cov s protein	16
a positive control	16
porcine epidemic diarrhea	16
peripheral blood mononuclear	16
vaccinated with prrs	16
blood mononuclear cells	16
effectiveness of the	16
of porcine reproductive	16
a concentration of	16
to understand the	16
public health and	16
an animal model	16
of the antigen	16
and identification of	16
immunity in mice	16
neutralizing antibody response	16
wild type virus	16
live virus vaccine	16
serve as a	16
antibodies against the	16
of modified vaccinia	16
the application of	16
were found in	16
carried out using	16
cellular and humoral	16
infectious peritonitis virus	16
could also be	16
the rn protein	16
regard to the	16
to meet the	16
antibody levels in	16
that the vaccine	16
neutralizing antibodies were	16
half of the	16
in the americas	16
it would be	16
time pcr assays	16
mucosal and systemic	16
arkga p vaccine	16
activation of the	16
antibody response to	16
with the same	16
as a positive	16
on day after	16
groups of mice	16
in a vaccine	16
lower than the	16
study of the	16
a member of	15
one dose of	15
cov spike protein	15
inactivated influenza vaccine	15
similar to those	15
antigen presenting cells	15
to be vaccinated	15
the day and	15
vaccine adverse events	15
lymph node cells	15
poly iclc and	15
work was supported	15
and development of	15
are needed to	15
in more than	15
pigs vaccinated with	15
avian coronavirus infectious	15
the virus was	15
in vaccine development	15
are summarized in	15
cells were then	15
after the last	15
of balb c	15
has to be	15
the viral vector	15
of influenza viruses	15
of vaccine adverse	15
it should be	15
parainfluenza virus type	15
has been demonstrated	15
lactis gem particles	15
efficacy and safety	15
and can be	15
the yellow fever	15
of new vaccines	15
advisory committee on	15
compared with those	15
antibodies in the	15
in the serum	15
lead to the	15
the exception of	15
are likely to	15
review and meta	15
data suggest that	15
was defined as	15
of vaccinia virus	15
the need to	15
the pathogenesis of	15
respiratory tract infections	15
vaccination coverage among	15
associated with influenza	15
at and days	15
of sars coronavirus	15
expression of a	15
higher than that	15
health care workers	15
cellular immune response	15
the day group	15
which is a	15
of the target	15
of health and	15
in of the	15
of the respiratory	15
the us and	15
group that received	15
majority of the	15
been found to	15
m and n	15
igg and iga	15
with that of	15
with a recombinant	15
and distribution of	15
and incubated with	15
was able to	15
two doses of	15
a future covid	15
responses in mice	15
with ml of	15
was extracted from	15
no significant differences	15
type i ifn	15
the m protein	15
this is the	15
used as the	15
in a mouse	15
serial passages in	15
vaccine candidates in	15
that had been	15
were used in	15
m and s	15
similar to that	15
and days after	15
effect of the	15
the extent of	15
to be more	15
conflict of interest	15
room temperature for	15
regions of the	15
the vaccine group	15
neutralizing antibodies and	15
is able to	15
rsv g and	15
result of the	15
may also be	15
expressed as the	15
as a control	15
presence of the	15
indicates that the	15
magnitude of the	15
differences between the	15
the sars coronavirus	15
adolescents and adults	15
a modified live	15
flow cytometric analysis	14
with a single	14
patient information leaflet	14
human and veterinary	14
of immune responses	14
in clinical trials	14
gene of the	14
were maintained in	14
a negative control	14
to the high	14
in the uk	14
responses induced by	14
be able to	14
the formation of	14
were analyzed by	14
the past years	14
of respiratory syncytial	14
vaccination in the	14
the age of	14
the virus and	14
appears to be	14
cell responses in	14
vaccines for the	14
for min and	14
indicate that the	14
acceptability of a	14
the wnv e	14
increased frequency of	14
in infants and	14
week after the	14
for human use	14
in the u	14
also observed in	14
vaccination with a	14
and use of	14
results in the	14
diagnosis of pertussis	14
animals vaccinated with	14
the addition of	14
after vaccination with	14
vaccine in a	14
administration of a	14
the united kingdom	14
the aim of	14
determined by the	14
response to a	14
the negative control	14
with pfu of	14
vaccine safety and	14
the group that	14
risk factors for	14
led to the	14
the loss of	14
were positive for	14
seen in the	14
virus capsid protein	14
an equal volume	14
day of age	14
live attenuated vaccines	14
avian influenza a	14
blood samples were	14
of the p	14
the s and	14
in the frequency	14
the most advanced	14
the viral rna	14
from the same	14
and s proteins	14
of influenza and	14
clinical signs were	14
carried out in	14
coronavirus associated with	14
studies have shown	14
animal models and	14
health center patients	14
the administration of	14
virus and the	14
results indicate that	14
associated with this	14
the pseudotype assay	14
the treatment of	14
can also be	14
epidemic diarrhea virus	14
reported in the	14
the secretion of	14
over the past	14
member of the	14
neutralizing antibody titer	14
funded health centers	14
in the early	14
the preparation of	14
immune responses of	14
the construction of	14
food and drug	14
making and implementation	14
of vaccines to	14
contrast to the	14
of vaccines and	14
followed by a	14
infectious bronchitis coronavirus	14
in line with	14
the characteristics of	14
influenza vaccination coverage	14
of the e	14
is one of	14
were performed in	14
it is also	14
position of the	14
significantly lower than	14
have the potential	14
health and human	14
and protective efficacy	14
a mouse model	14
may be a	14
the viral load	14
at a dose	14
of a future	14
vaccine candidates are	14
the response to	14
the s subunit	14
of the placebo	14
on day of	14
the occurrence of	14
cats of the	14
cervical lymph node	13
the influenza vaccine	13
human mhc class	13
the centers for	13
the nucleocapsid protein	13
of the severe	13
were subjected to	13
high titers of	13
reaction was stopped	13
used as an	13
deletion of the	13
in the usa	13
as described by	13
the virus is	13
spread of the	13
lethal challenge with	13
at a concentration	13
nature of the	13
were significantly higher	13
tr protein expression	13
determined to be	13
a clinical trial	13
conjugated goat anti	13
in agreement with	13
lower than that	13
global public health	13
in vaccinated and	13
infants and children	13
systemic and mucosal	13
of an inactivated	13
were tested for	13
to be safe	13
may contribute to	13
the result of	13
for this study	13
funded by the	13
may be the	13
of the covid	13
of these vaccines	13
of infection in	13
mice vaccinated with	13
plates were washed	13
were examined for	13
of transmissible gastroenteritis	13
on days and	13
the day of	13
suggests that the	13
did not induce	13
the lungs of	13
study was to	13
and pandemic influenza	13
as for the	13
the course of	13
comparable to that	13
and stained with	13
to pay for	13
the recombinant protein	13
the vaccine strain	13
the early s	13
high level of	13
s and n	13
was detected at	13
at the n	13
t h response	13
can serve as	13
of vaccines in	13
in healthy adults	13
may lead to	13
in humans and	13
of pandemic influenza	13
that there are	13
the modified live	13
and respiratory syncytial	13
a vaccine for	13
associated with severe	13
as a means	13
in the following	13
the mice were	13
calves in herd	13
viral rna was	13
were divided into	13
the most effective	13
dose of the	13
purified inactivated sars	13
of vaccine safety	13
due to its	13
vector and vaccine	13
to those of	13
the disease burden	13
is the first	13
confirmed influenza pneumonia	13
mucosal immune system	13
this study is	13
were included as	13
passive transfer of	13
in a number	13
day after the	13
the acceptability of	13
did not show	13
incubated for min	13
syndrome coronavirus infection	13
presence of a	13
a means of	13
is required for	13
and human health	13
could be detected	13
in this experiment	13
to examine the	13
lower respiratory tract	13
resulted in the	13
and of the	13
g ml of	13
all rights reserved	13
role of the	13
to the development	13
out of the	13
the west nile	13
it was not	13
is capable of	13
and have been	13
in young children	13
vaccines and vaccination	13
in public health	13
mice that received	13
for h and	13
there are several	13
and duration of	13
t cells are	13
but not in	13
in this regard	13
to be considered	13
the spike gene	13
care and use	13
to compare the	13
was used in	13
were performed using	13
the process of	13
innate and adaptive	13
for protection against	12
the in vivo	12
of human immunodeficiency	12
be attributed to	12
characteristics of the	12
detection of the	12
are expected to	12
and human services	12
the beginning of	12
animal care and	12
intranasal administration of	12
the v swg	12
this suggests that	12
after the third	12
to create a	12
t cell epitopes	12
caused by a	12
proved to be	12
were compared with	12
using the same	12
were measured by	12
protein expression in	12
serial dilutions of	12
pathogenic avian influenza	12
need for a	12
did not have	12
response to vaccination	12
the attenuation of	12
animal and human	12
results of this	12
the stimulation of	12
the establishment of	12
molecular weight of	12
was assessed by	12
attenuated vaccinia virus	12
a single immunization	12
of cases of	12
clinical trials in	12
cells were incubated	12
the ive against	12
to protect against	12
stability of the	12
and humoral immune	12
the results are	12
h n vaccines	12
there is an	12
neutralizing antibody responses	12
been observed in	12
belonging to the	12
to induce a	12
and control of	12
subgroups a and	12
in the host	12
incidence of diarrhoea	12
to be an	12
of antibodies to	12
received the vaccine	12
only a few	12
the cause of	12
vero e cells	12
s and s	12
of the cell	12
specific immune response	12
the e gene	12
capable of inducing	12
influenza h n	12
before and after	12
impact on the	12
for the vaccine	12
the existence of	12
the study was	12
and mvaik rsv	12
low levels of	12
the site of	12
of cd and	12
recommendations of the	12
antibody responses in	12
mice were sacrificed	12
antibody response in	12
the health center	12
will be the	12
cervical lymph nodes	12
were coated with	12
influenza vaccine uptake	12
were analyzed using	12
responses against sars	12
each sample was	12
administration of the	12
avian influenza viruses	12
total number of	12
in pigs vaccinated	12
open reading frame	12
of a covid	12
dose of pfu	12
vaccine efficacy and	12
is caused by	12
infectious bronchitis viruses	12
number of studies	12
which is the	12
are required for	12
bronchitis virus in	12
in relation to	12
this is a	12
this indicates that	12
was performed to	12
infected with a	12
the persistence of	12
in mice immunized	12
are known to	12
and h n	12
at this time	12
as a negative	12
to increase the	12
yellow fever vaccine	12
canine parvovirus type	12
and drug administration	12
plays an important	12
in the human	12
of a modified	12
been associated with	12
full s mf	12
heard of h	12
of nucleic acid	12
with a high	12
of otitis media	12
the opportunity to	12
difference between the	12
intranasal delivery of	12
vero cells were	12
introduction of the	12
rotavirus and coronavirus	12
vaccinated against covid	12
the growth of	12
of ebola virus	12
results from the	12
of rabies in	12
that it is	12
countries in the	12
of the global	12
in cho dhfr	12
sequencing of the	12
group of experts	12
was shown to	12
of feline infectious	12
memory cd t	12
against west nile	12
against myxomatosis and	12
for at least	12
in this report	12
after the first	12
yellow fever virus	12
there was an	12
to determine if	12
for control of	12
on day post	12
specific cytotoxic t	12
use as a	12
be noted that	12
results show that	12
disease burden of	12
will need to	12
and young children	12
risk assessment of	12
secretion of il	12
genetic stability of	12
and adaptive immune	12
coronavirus spike glycoprotein	12
that they are	12
this age group	12
the middle east	12
protective effect of	12
is possible to	12
for influenza a	12
views on the	12
not statistically significant	12
the distribution of	12
based on these	12
developed by the	12
burden of influenza	12
with an equal	12
for a covid	12
in the generation	12
the results indicated	12
for older adults	12
for respiratory disease	12
of virus in	12
key considerations for	12
oral administration of	12
min at room	12
working group on	12
by the vaccine	12
central nervous system	12
influenza and other	12
the prevalence of	12
proven to be	12
together with the	12
a viral vector	12
influenza a viruses	12
the cd t	12
responses to vaccines	12
and protection against	12
in the world	12
hong kong and	12
c bl mice	11
determined by elisa	11
can be seen	11
in rhesus monkeys	11
were housed in	11
of avian influenza	11
immune response against	11
to take siv	11
on the acceptability	11
was performed in	11
influenza viruses in	11
the mhc class	11
increased risk of	11
to prevent the	11
properties of the	11
with rsv subgroup	11
appeared to be	11
vaccine may be	11
to produce a	11
with a dose	11
the period of	11
hek t cells	11
cell responses to	11
in this case	11
and the results	11
data were analyzed	11
mortality in the	11
the onset of	11
was significantly higher	11
and igg a	11
both humoral and	11
against h n	11
in the viral	11
of the second	11
at years post	11
for public health	11
by the national	11
the working group	11
of enhanced disease	11
was lower than	11
of nk cells	11
a history of	11
able to induce	11
titers of the	11
dilution of the	11
data indicate that	11
the relative importance	11
means of preventing	11
against lethal challenge	11
immune response and	11
dna vaccine induces	11
can lead to	11
determination of the	11
immunogenicity and protective	11
for this purpose	11
committee on immunization	11
studies have been	11
its ability to	11
was not observed	11
the cervical lymph	11
safety working group	11
serial passage in	11
the samples were	11
in the sera	11
an example of	11
compared to those	11
was measured by	11
to obtain a	11
expression of cd	11
this type of	11
use of vaccines	11
in comparison with	11
chickens inoculated with	11
can be achieved	11
protein is a	11
and its derivatives	11
of the three	11
were cultured in	11
classical swine fever	11
of the individual	11
the supernatant was	11
of disease enhancement	11
have been found	11
the form of	11
of dendritic cells	11
mouse hepatitis virus	11
contributed to the	11
the influenza virus	11
time of first	11
development of new	11
respiratory infections in	11
efforts to develop	11
the vector and	11
the challenge of	11
total rna was	11
to test the	11
many of these	11
borne encephalitis virus	11
that there was	11
then challenged with	11
single immunization with	11
the basis for	11
a determinant of	11
suggested that the	11
days prior to	11
attenuated influenza vaccine	11
highly pathogenic avian	11
is a major	11
was performed on	11
is difficult to	11
of rabies virus	11
is that the	11
groups of balb	11
vaccine candidate for	11
immunogenicity and safety	11
were shown to	11
other respiratory viruses	11
influenza a and	11
was collected and	11
probability of vaccine	11
reciprocal of the	11
willingness to pay	11
the ratio of	11
we would like	11
focused on the	11
by the s	11
spike protein is	11
of a sars	11
immunity in the	11
analyses were performed	11
were associated with	11
of vaccine development	11
is also a	11
participate in the	11
the disease is	11
n influenza virus	11
have demonstrated that	11
development of an	11
natural killer cells	11
between cases and	11
the amino acid	11
as evidenced by	11
on the basis	11
to estimate the	11
immunized with the	11
of cell culture	11
vaccinated and control	11
the general population	11
the development and	11
version of the	11
in the production	11
of the birds	11
in children with	11
to a lesser	11
mice were challenged	11
blood was collected	11
the analysis of	11
eggs were inoculated	11
of first vaccination	11
infection in the	11
reduction in viral	11
global vaccine action	11
the vaccine in	11
which has been	11
challenged with sars	11
of the innate	11
amino acid sequence	11
influenza vaccines in	11
west nile vaccine	11
of the different	11
oral polio vaccine	11
in the second	11
to be highly	11
of the current	11
also be used	11
and has been	11
of the original	11
n influenza vaccine	11
been reported that	11
respect to the	11
in the group	11
results of a	11
wnv e glycoprotein	11
of the inactivated	11
frequency of ifn	11
a pool of	11
efficacy of an	11
it is difficult	11
at day and	11
previous studies have	11
cells of the	11
of the challenge	11
what is the	11
of the last	11
iclc and le	11
amino acid substitutions	11
cells were used	11
the disease in	11
specific for the	11
adaptive immune response	11
and the virus	11
safety of the	11
and le poly	11
to ensure the	11
the inactivation process	11
immunogenicity of an	11
one week after	11
in a covid	11
doses of the	11
to confirm the	11
s yz strains	11
shown to induce	11
than in the	11
specific neutralizing antibodies	11
a protective immune	11
patients with severe	11
the protective efficacy	11
the design of	11
production of a	11
innate immune system	11
was tested in	11
a study of	11
of vaccines against	11
of acute otitis	11
hepatitis c virus	11
for use as	11
followed by the	11
vaccine action plan	11
the reciprocal of	11
responses to the	11
that there is	11
ndv or ampv	11
influenza vaccine and	11
vaccine and placebo	11
estimated to be	11
public health emergency	11
were based on	11
was added and	11
for prevention of	11
was analyzed by	11
of viral replication	11
response against the	11
and that the	11
for epidemic preparedness	11
is replication incompetent	10
was calculated by	10
vaccine for the	10
african green monkeys	10
vaccine and the	10
titer of the	10
were expressed as	10
demonstrate that the	10
disease prevention and	10
component of the	10
a recent study	10
for this reason	10
recombinant swinepox virus	10
with the potential	10
of human and	10
viral replication in	10
the membrane was	10
more prone to	10
transmission of the	10
vaccination arrangement procedure	10
the inactivation of	10
the determination of	10
of the beaur	10
with elevated activity	10
the causative agent	10
in the spike	10
was not detected	10
of all the	10
should be noted	10
respiratory tract of	10
have been the	10
in the online	10
and function of	10
world health organisation	10
cell epitopes in	10
of this approach	10
live attenuated vaccine	10
number of children	10
been reported to	10
they are not	10
has the potential	10
year of life	10
and m proteins	10
in light of	10
the highest dilution	10
after challenge with	10
positive for influenza	10
spf chicken eggs	10
infection and disease	10
parts of the	10
during the influenza	10
into three groups	10
no difference in	10
an effective vaccine	10
has recently been	10
the trachea and	10
the release of	10
ampv subtype b	10
of b cells	10
of the viruses	10
found that the	10
for each group	10
virus as a	10
of mtb wcl	10
only in the	10
linked immunosorbent assay	10
syncytial virus infection	10
the vaccinated mice	10
by the manufacturer	10
source of infection	10
the diagnosis of	10
different time points	10
coronavirus nucleocapsid protein	10
children in the	10
the objective of	10
the significance of	10
the source of	10
is required to	10
such as influenza	10
binding domain of	10
will not be	10
vector vaccines safety	10
to influenza virus	10
novel coronavirus associated	10
in mdck pf	10
the t cell	10
mhc class ii	10
protection against lethal	10
producing cd t	10
were observed for	10
a group of	10
for vaccine production	10
and nk cells	10
was observed after	10
the vaccine to	10
the titers of	10
institutional animal care	10
diarrhoea and mortality	10
the selection of	10
according to their	10
shown in the	10
chickens infected with	10
significant reduction in	10
induce protective immunity	10
rsv subgroups a	10
relative importance of	10
in insect cells	10
the disease and	10
thought to be	10
information and patient	10
and there is	10
was due to	10
resulting in a	10
the mucosal immune	10
be involved in	10
was performed with	10
vaccination of hcws	10
hepatitis b virus	10
in the as	10
to the virus	10
as a vector	10
in some countries	10
the global vaccine	10
and new zealand	10
influenza virus in	10
induced by a	10
three times with	10
sequence analysis of	10
after the challenge	10
we investigated the	10
a significantly higher	10
of the first	10
the association of	10
in mammary secretions	10
protection against virulent	10
infants and young	10
into account the	10
the specificity of	10
the national institutes	10
the plate was	10
b nasal spray	10
of infectious virus	10
course of the	10
mdck pf cells	10
against canine visceral	10
the reaction was	10
immunization of mice	10
against rabies virus	10
subjects in the	10
antibody response was	10
viral replication and	10
large numbers of	10
to the sars	10
a subset of	10
and the potential	10
role of complement	10
chadox mers with	10
vaccines are available	10
was significantly lower	10
resulting in the	10
in health care	10
difference in the	10
a mixture of	10
show that the	10
of the coronavirus	10
was expressed as	10
epitopes of the	10
the cattery cats	10
we did not	10
three groups of	10
proteins of avian	10
responses and protection	10
in clinical development	10
in the number	10
host range and	10
i and ii	10
to produce the	10
collected from the	10
phase i clinical	10
s protein of	10
effectiveness of influenza	10
prescribing information and	10
the threat of	10
differences were observed	10
have been tested	10
pulmonary viral titer	10
against rsv subgroup	10
of our study	10
has been developed	10
change in the	10
immunogenicity and efficacy	10
n and n	10
shown that the	10
of adverse events	10
for influenza vaccination	10
the virus in	10
in phase i	10
possible that the	10
the inclusion of	10
vaccine group and	10
with l of	10
as the mean	10
the influenza season	10
spf eggs were	10
t cells from	10
response to influenza	10
specific memory t	10
implications for the	10
different age groups	10
develop a vaccine	10
t cells was	10
on the cell	10
guangzhou and hong	10
and the vaccine	10
immunization with a	10
s protein is	10
diseases such as	10
i ifn signaling	10
gene expression in	10
and patient information	10
is critical for	10
to define the	10
effect on the	10
vaccination of the	10
in a recent	10
of the vaccines	10
of the inactivation	10
of mycobacterium tuberculosis	10
the observation period	10
class i molecules	10
noted that the	10
provided by dr	10
sequences of the	10
the pbs control	10
to have an	10
major histocompatibility complex	10
of the infected	10
inoculated intranasally with	10
not included in	10
different doses of	10
and protective immunity	10
the online version	10
expression in mammalian	10
to replicate in	10
united states and	10
monoclonal antibodies against	10
h at room	10
were collected on	10
in the incidence	10
in human cells	10
at mucosal sites	10
in collaboration with	10
a potent adjuvant	10
coalition for epidemic	10
is due to	10
oral vaccination of	10
access to vaccines	10
days and post	10
vaccines safety working	10
in the form	10
of diarrhoea and	10
of the initial	10
in spite of	10
culture supernatants were	10
the goal of	10
the sera of	10
mediated by the	10
inoculated with the	10
specific igg and	10
the total number	10
the other two	10
we show that	10
viral vector vaccine	10
of the assay	10
for up to	10
be achieved by	10
pcr assay for	10
live attenuated influenza	10
a vaccine clinical	10
of protective immunity	10
level of neutralizing	10
a role for	10
were serially diluted	10
p vaccine candidate	10
american indian alaska	10
at the site	10
the european union	10
with a higher	10
and hong kong	10
the results obtained	10
live and inactivated	10
could be a	10
the animals were	10
of the m	10
a and c	10
and modified vaccinia	10
induction of protective	10
well as a	10
were inoculated by	10
the department of	10
of the potential	10
mutations in the	10
fact that the	10
to porcine reproductive	10
washed three times	10
influenza vaccination among	10
in protection against	10
h and h	10
amino acid sequences	10
been demonstrated to	10
surface of the	10
on the use	10
is shown in	10
of the h	10
of c b	10
and n proteins	10
defined as the	10
of viral rna	10
antibody response against	10
is thought to	10
are able to	10
of rift valley	10
an influenza vaccine	10
the viral genome	10
in dromedary camels	10
of the vaccination	10
intending to take	10
not significantly different	10
some of these	10
final concentration of	10
the cell surface	10
which could be	10
of the host	10
vaccines that are	10
of the serum	10
were approved by	10
immune response by	10
similar results were	9
vaccine in healthy	9
virus infection of	9
of antigenic sites	9
should be considered	9
in europe and	9
revealed that the	9
of the live	9
groups that received	9
in the years	9
burden of disease	9
mouth disease in	9
infection in humans	9
pay for a	9
exon splicing enhancers	9
occurred in the	9
protection against challenge	9
of five mice	9
of vesicular stomatitis	9
of interest to	9
number of animals	9
was seen in	9
used to evaluate	9
for influenza vaccines	9
human monoclonal antibodies	9
nasal delivery of	9
clinical development of	9
myxomatosis and rabbit	9
the differences between	9
not yet been	9
and the use	9
those in the	9
the st century	9
ibv vaccinated groups	9
the purified rha	9
for collection of	9
in the treatment	9
were also found	9
no significant difference	9
it is estimated	9
indian alaska native	9
in the south	9
the virus suspension	9
animals to humans	9
one of these	9
in pig lungs	9
higher than in	9
were taken from	9
and b malaysia	9
for many years	9
it was found	9
clarified by centrifugation	9
reversion to virulence	9
in the next	9
studies suggest that	9
of these viruses	9
of animal diseases	9
in countries with	9
from the national	9
in conjunction with	9
divided by the	9
when compared with	9
should also be	9
pneumococcal conjugate vaccine	9
old female balb	9
we have demonstrated	9
systematic review of	9
the replication of	9
and specificity of	9
did not increase	9
followed by incubation	9
was a significant	9
in severe acute	9
of the manuscript	9
was also observed	9
haemorrhagic disease virus	9
were mixed with	9
are grateful to	9
of one or	9
for the evaluation	9
time pcr assay	9
th and th	9
and to a	9
level of protection	9
of the wnv	9
no evidence of	9
public health impact	9
cause of severe	9
of up to	9
pandemic h n	9
virus is a	9
analysis showed that	9
be detected in	9
in the lung	9
the s tr	9
the virus to	9
large number of	9
concentration of the	9
mucosal immune responses	9
is a determinant	9
tested positive for	9
for pandemic influenza	9
and influenza virus	9
the intranasal route	9
supernatants were collected	9
this study were	9
of human disease	9
in the virus	9
is necessary to	9
humoral and cell	9
dilutions of the	9
for induction of	9
are those of	9
data associated with	9
iga and igm	9
and mucosal immunity	9
nucleocapsid protein of	9
infections in the	9
reported to be	9
human monoclonal antibody	9
binding to the	9
of disease in	9
of avian coronavirus	9
the creation of	9
titer was determined	9
the n peptide	9
the study of	9
under field conditions	9
variation in the	9
those who are	9
animals in the	9
immune responses that	9
is believed to	9
of protection against	9
health of the	9
the health of	9
the mechanism of	9
did not differ	9
as negative control	9
of which are	9
of the protein	9
sensitivity and specificity	9
viruses and their	9
an immune response	9
advances in the	9
even in the	9
health resources and	9
rn protein formulated	9
leading cause of	9
of vaccination against	9
and cellular immunity	9
of an effective	9
the work of	9
in the general	9
diseases in the	9
of a rtv	9
to this article	9
a source of	9
as early as	9
chitosan and its	9
relative to the	9
the genome of	9
efficacy and effectiveness	9
protein of severe	9
sars vaccine was	9
colleagues intending to	9
in some cases	9
corresponding to residues	9
the highest antibody	9
discrete choice experiment	9
of the ifn	9
be included in	9
receptor binding domain	9
m and g	9
may be due	9
based vaccine candidates	9
are presented in	9
result in the	9
as determined by	9
at least two	9
for production of	9
of the other	9
there may be	9
pigs inoculated with	9
the cellular immune	9
for clinical signs	9
infection of the	9
to the control	9
be safe and	9
cost of the	9
in the faeces	9
all of these	9
the properties of	9
viral and bacterial	9
an influenza pandemic	9
seems to be	9
expanded programme on	9
to influenza vaccination	9
been tested in	9
higher than those	9
used in a	9
the first immunization	9
or mvaik rsv	9
with this article	9
were defined as	9
protection against a	9
replication in the	9
resulted in an	9
in viral titer	9
pfu ml in	9
global burden of	9
the rate of	9
recombinant measles virus	9
the changes in	9
recombinant vaccinia viruses	9
vaccination and the	9
was based on	9
with the highest	9
and in vitro	9
with g ml	9
because it is	9
of more than	9
had the lowest	9
as vaccine vectors	9
by using the	9
truncated g protein	9
measles vaccine expressing	9
to develop an	9
analysis of variance	9
infection with the	9
to bordetella pertussis	9
virus was detected	9
challenged with the	9
and services administration	9
pbs control group	9
antibody in the	9
old spf chickens	9
and risk factors	9
against sars cov	9
we used the	9
be difficult to	9
this is in	9
days after challenge	9
of the antibodies	9
an outbreak of	9
the experimental group	9
and effectiveness of	9
an analysis of	9
the specific igy	9
low and middle	9
vaccine candidates were	9
risk benefit assessment	9
s protein was	9
were conducted in	9
human igg fc	9
smallpox vaccine in	9
number of vaccines	9
of the complement	9
a vaccine is	9
cloned mdck cells	9
than the placebo	9
serum samples from	9
in these animals	9
inoculated with p	9
in the poultry	9
a cohort of	9
was incubated with	9
s yz strain	9
of the beaudette	9
derived from a	9
been reported in	9
demonstrates that the	9
strain in the	9
in the final	9
monoclonal antibodies to	9
day and day	9
there are no	9
after a single	9
rather than the	9
of pertussis in	9
as a live	9
bronchitis virus strain	9
higher levels of	9
and avian influenza	9
be explained by	9
field strains of	9
the chicks were	9
in a clinical	9
for diagnosis of	9
a combination of	9
were observed daily	9
in west africa	9
h n pdm	9
isolated from a	9
were performed with	9
a comparison of	9
it is worth	9
significant difference at	9
c measles vaccine	9
based tgev vaccine	9
strand rna viruses	9
and field strains	9
by the us	9
the advisory committee	9
when the vaccine	9
that had received	9
and l of	9
duration of the	9
in mdck cells	9
of the th	9
study showed that	9
with and without	9
rsv subgroup b	9
dose of vaccine	9
found to have	9
correlates of immunity	9
on immunization practices	9
resources and services	9
test was used	9
periods with elevated	9
kindly provided by	9
genbank accession number	9
were detected at	9
for the expression	9
the transmission of	9
significantly associated with	9
play a role	9
of the data	9
response in mice	9
vaccines in the	9
the population of	9
cells and the	9
for influenza virus	9
than that in	9
s gene of	9
after the second	9
the immune responses	9
neutralizing antibody levels	9
that received the	9
the human mhc	9
or f protein	9
of yellow fever	9
specific t cell	9
wild rabbit populations	9
of the four	9
has been described	9
during the period	9
oral bait vaccine	9
years and older	9
in the non	9
assay for the	9
was found that	9
disease burden in	9
be considered as	9
four groups of	9
the vaccine virus	9
structural proteins of	9
as the reciprocal	9
supplementary data associated	9
protection of the	9
for the purpose	9
the degree of	9
specific pathogen free	9
the neutralization titer	9
and challenged with	9
cho cell line	9
by means of	9
were similar to	9
the human immunodeficiency	9
were purchased from	9
of the highest	9
be an important	9
the titer of	9
and the other	9
was treated with	9
during the pandemic	9
but did not	9
g or vsv	9
used to determine	9
n and h	9
each age group	9
immune system to	9
the e glycoprotein	9
ibv and ampv	9
protection against the	9
system for the	9
mm sodium phosphate	9
domain of the	9
nt antibodies against	9
do not have	9
with the recombinant	9
on the s	9
replication of the	9
the adjuvanticity of	9
to better understand	9
of the control	9
among healthcare workers	9
from lymph nodes	9
in a large	9
linked to the	9
of the aik	9
the change in	9
there are many	9
and use committee	9
acute phase proteins	9
was similar to	9
in ovo vaccination	9
neutralizing antibody and	9
to respond to	9
in this trial	9
the pathogenicity of	9
of inactivated influenza	9
as a potential	9
protein of sars	9
of the gene	9
of zika virus	9
local and systemic	9
period of time	9
a safe and	9
was confirmed by	9
vaccinated with a	9
the protection of	9
get vaccinated against	9
by western blot	9
of a high	9
acellular pertussis vaccines	9
vaccines can be	9
divided into three	9
were unable to	9
of the rbd	9
t cell epitope	9
proteins in the	9
which can be	9
type of immune	9
eid of the	8
among health care	8
are responsible for	8
the range of	8
an increased frequency	8
lc m and	8
genetically modified l	8
phase iii trials	8
infectious virus was	8
from patients with	8
dna vaccine encoding	8
kong and singapore	8
in part by	8
used to describe	8
infectious diseases with	8
were seen in	8
an inactivated vaccine	8
for the construction	8
vaccine expressing the	8
mutation in the	8
in the eu	8
mediated immune responses	8
by pcr using	8
immune responses induced	8
that does not	8
in a phase	8
human clinical trials	8
data demonstrate that	8
with hepatitis b	8
or in combination	8
there are still	8
commercial broiler chicks	8
older adults and	8
epidemic preparedness innovations	8
fold higher than	8
divided into four	8
and did not	8
in the ibv	8
been developed by	8
were stimulated with	8
vaccine prepared from	8
were derived from	8
with the rh	8
of vaccine candidates	8
influenza vaccine production	8
was detected by	8
an attempt to	8